Montreux Capital Management, Advisor of the Montreux Care Home Fund and the Montreux Commodity Fund, has appointed hedge fund pioneer Ian Morley as its chairman.

A founding member of the original European ‘fund of hedge funds’ as well as the hedge fund managers’ trade association, the Alternative Investment Management Association, Morley is one of a number of appointments that the three-year old firm has made as it seeks to expand its alternative investment slate.

Morley, who will also head up corporate governance within the company, was part of the original London Phibro team which made markets in gold and other precious metals outside the historic fixing members of the London gold market.

He said of his appointment: “I am delighted to take on this new role as chairman of Montreux Capital. This growing firm and engaging management team are focusing on the creative investment area of truly diversified alternatives.”

Piers Sword, head of operations and distribution, added: “It is a testament to our development as a company and the success of the funds that we manage that we have someone of Ian Morley’s reputation and stature on staff.”

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

ACCEPT